Management of Systemic Lupus Erythematosus

Slides:

Advertisements

Similar presentations

5S CLÍNICA MÉDICA (MH) 306 A. 5S CLÍNICA MÉDICA (MH) 306 B.

Advertisements

Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Small-Diameter Nerve Fiber Neuropathy in Systemic.

Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.

Dry Eye Disease: Pathophysiology, Symptoms, Intervention

The Aortic Valve Patient Learning Objectives

Upfront Combination Therapy vs Step-Up Approach for PAH:

Education program ( system). Education program ( system)

The Patient Experience With Systemic Lupus Erythematosus

Medical Nutrition Therapy is

Copyright © 2004 American Medical Association. All rights reserved.

Optimal Management of Spinal Muscular Atrophy

HIV-Associated Weight Loss and Wasting

Systemic Lupus Erythematosus

COPD by the Guidelines.

Clinical Trials in IBD.

Introduction to medical Terminolog MEDICAL TERMINOLOGY.

Why Gene Therapy for Hemophilia?

Gout Management.

Medical Factors Affecting Older Driver Safety

Does One Size Fit All in Obesity Management?

Clinical Trials to Real World:

Modern Strategies for Basal Insulin Use in T2D

Pediatric Antiepileptic Treatment Strategies

Early Dementia Distinguishing AD From MCI

The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.

Strategies for Assessing and Preserving Function in ALS

Optimizing Outcomes in the Management of GIST

Resistant Hypertension

Chronic Idiopathic Urticaria

When Patients With Depression Have Cognitive Deficits

Follow-Up of the Patient After PE

Program Introduction. Monoclonal Antibodies and Immunogenicity: Relevance to Clinical Practice?

Expert Perspectives on Hyperkalemia for the Specialist

The Shrinking Lungs Syndrome in Systemic Lupus Erythematosus

Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.

Improving Outcomes in OSA

Time between systemic lupus erythematosus (SLE) and haematological malignancy diagnoses. Time between systemic lupus erythematosus (SLE) and haematological.

Supplementary Figure 1. Longitudinal study in a representative number of SLE patients one year before (t1), at the time (t2), and one year after renal.

Exploring Personalized Prophylaxis in Hemophilia A

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

A Primer on Medication Delivery Systems in COPD Management

Battling Constipation

Clinical Recognition and Treatment of Levodopa-Induced Dyskinesia

HIV Treatment: What Can You Do to Get and Keep Patients in Care?

New Recommendations on How to Stage Hidradenitis Suppurativa

Hidden in Plain Sight: Disrupted Sleep in Patients With Pain

Introduction. Clinical Scenario: Encouraging Adherence in Patients with Schizophrenia.

The Mitral Valve Patient Learning Objectives

Management of Systematic Lupus Erythematosus

Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.

Providing Hope and Opportunity

A Primer on Medication Delivery Systems in COPD Management

SLE and Cardiovascular Risk

Nat. Rev. Nephrol. doi: /nrneph

Systemic Lupus Erythematosus

Guide to Atopic Dermatitis

Optimizing Joint Health in Hemophilia

Critical Decision Points in Insomnia

Updates in RA, PsA, and Biosimilars

Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.

Case Studies in Peanut Allergy Immunotherapy

Longitudinal changes in serum G3BP concentrations and SLEDAI in 15 patients with SLE. Each plot represents one patient. Longitudinal changes in serum G3BP.

Correlation between frequency of Th17 cells and disease activity or amount of proteinuria in patients with systemic lupus erythematosus (SLE). Correlation.

Merging the Art and Science of Managing nOH in Clinical Practice

The Building Blocks of Homocystinuria and Homocysteinemia Management

What's New in PAH?.

Ask the Psoriasis Expert

Motor Fluctuations in PD

Best Practices in Building HIV Care Networks

Presentation transcript:

Management of Systemic Lupus Erythematosus

Introduction to Fatigue in SLE

Causes of Fatigue That May or May Not Be Directly Related to SLE

Assessing Fatigue in Patients With SLE

Measuring Fatigue Not So Practical in Clinical Settings

Commonly Used Patient-Reported Outcomes Measures

SLE Medications Can Contribute to Fatigue

Managing Fatigue in Patients Psychosocial Interventions

Managing Fatigue in Patients Physical Activity and Diet

Managing Fatigue in Patients Vitamin D Supplementation

Managing Fatigue in Patients Pharmacologic Intervention

Team-Based Strategies in Management of Fatigue in SLE

Concluding Remarks

Abbreviations